Santen Pharmaceutical Co (JP:4536) has released an update.
Santen Pharmaceutical Co. has announced the cancellation of 16,985,400 treasury shares, representing 4.7% of its outstanding shares, with the action set to be completed by November 29, 2024. This strategic move is expected to leave the company with 347,036,854 outstanding shares, streamlining its share structure.
For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.